As of June 2021, the United States FDA requires pharma and life sciences companies to submit post-marketing and pre-clearance materials electronically.
Learn more tips for implementing the FDA’s guidance on electronic submissions.
As of June 2021, the United States FDA requires pharma and life sciences companies to submit post-marketing and pre-clearance materials electronically.
Learn more tips for implementing the FDA’s guidance on electronic submissions.